Nyhet -

Bergenstråhle & Partners continues to grow!

We are very excited to welcome Håkan Yildirim to Bergenstråhle & Partners!

Håkan will join Bergenstråhle’s Stockholm office as a patent attorney.

Håkan has been working as a patent consultant since 2012 and he has a broad knowledge and interest in natural sciences and is specialized in chemistry and medical sciences. He holds a Ph.D. in bioanalysis from Karolinska Institutet where he conducted cross-disciplinary research on biological polymers in order to identify potential vaccine candidates. He started off his career in the world of patents at the Swedish Patent and Registration office where he worked as a patent examiner for five years in the fields of chemistry, pharmaceuticals and biotechnology.

Håkan, with his expertise in various fields and his experience from the patent industry will be a great asset for us here at Bergenstråhle.

Welcome to the team, Håkan!

Ämnen

  • Juridik

Kategorier

  • immaterialrätt
  • patent
  • attorney
  • ip
  • ipr
  • life science

Kontakter

Ola Bergfeldt

Presskontakt CMO, Management Team Kommunikation, press- och mediakontakter, samarbetsförfrågningar +46 70-492 61 11

Pär Eliasson Zucco

Presskontakt VD, Management Team +46 70 347 40 61

Joakim Hernström

Presskontakt CBO, Management Team Head of Business Development, IP Strategy & Management +46 70 768 70 05

Petra Knoop Udén

Presskontakt COO, Management Team Attorney at Law, Authorized European Trademark And Design Attorney +46 72 569 24 10

Relaterat innehåll

Get to know Bergenstråhle's Anna Fokina

We had a chat with one of our exciting colleagues; Anna Fokina, and we would like to take the opportunity to introduce her and her interesting background.

​Håkan Yildirim holds lecture on FTO strategy at Stockholm University

This Saturday Bergenstråhle’s Håkan Yildirim will hold a lecture on Freedom-to-operate for students studying the “Industrial Property - Patents and Trademarks” course. The focus will be freedom-to-operate assessments is the field of chemistry and pharmaceuticals. Moreover, commercial and legal aspects of infringement will also be discussed.